Onyx Pharmaceuticals buy wiltrud
Start price
30.03.12
/
50%
€28.37
Target price
25.04.12
€34.50
Performance (%)
23.94%
End price
25.04.12
€35.16
Summary
This prediction ended on 25.04.12 with a price of €35.16. The BUY prediction by wiltrud finished with a performance of 23.94%. wiltrud has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Onyx Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by wiltrud for this prediction
In the thread Onyx Pharmaceuticals diskutieren
Bekommt Onyx die zweite Zulassung ?
kalifornische Biotech-Unternehmen steht vor der Zulassung seines zweiten Medikaments. Ein Erfolg könnte zu steigenden Kursen führen.
<!-- /BLOCK 4 -->